Researchers evaluated demographic characteristics associated with survival trends in patients with squamous cell carcinoma of the upper esophagus.

Esophageal squamous cell carcinoma (ESCC ... levels and found that high levels were associated with shorter overall survival, highlighting the potential of these proteins as prognostic markers.

Preliminary phase 1/1b dose expansion results of the bifunctional EGFR/TGFβ inhibitor ficerafusp alfa (BCA101) with pembrolizumab in patients with squamous cell carcinoma of the anal canal. This is an ...

A novel treatment approach combining neoadjuvant immunotherapy with chemoradiation showed promising results in patients with locally advanced esophageal squamous cell carcinoma (ESCC), according ...

Lobectomy for stage 1A NSCLC offered the highest survival rates, with a five-year overall survival (OS ... includes a majority of lung cancer and esophageal cancer surgeries performed in the ...

The primary endpoint is Overall ... month survival rate of 52.4%, with a median OS not yet reached, and a generally tolerated safety profile. Head and neck cancer ranks as the 7th most common cancer ...

Backgrounds: Trimodal therapy (neoadjuvant chemoradiotherapy followed by esophagectomy) for locally advanced esophageal squamous cell carcinoma (ESCC ... to evaluate the prognostic value of TRG for ...

Objectives: The efficacy and safety of neoadjuvant immunochemotherapy (nICT) are widely explored in locally advanced esophageal squamous cell carcinoma (ESCC ... response are summarized in Table 2.